Trial in progress: Neoadjuvant immune checkpoint blockade in resectable malignant pleural mesothelioma.

TPS9078Background: While the role of surgery in limited-stage (stage I-III) malignant pleural mesothelioma (MPM) is controversial, many centers have adopted an aggressive tri-modality approach inco...